Commentary: Polycystic ovary syndrome: A syndrome of ovarian hypersensitivity to insulin?

被引：114

作者：

Baillargeon, JP ^{[1
]}

Nestler, JE

机构：

[1] Univ Sherbrooke, Dept Med, Div Endocrinol, Sherbrooke, PQ J1H 5N4, Canada

[2] Virginia Commonwealth Univ, Dept Med, Richmond, VA 23298 USA

[3] Virginia Commonwealth Univ, Dept Obstet & Gynecol, Richmond, VA 23298 USA

来源：

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM | 2006年 / 91卷 / 01期

基金：

加拿大健康研究院;

关键词：

D O I：

10.1210/jc.2005-1804

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：22 / 24

页数：3

共 20 条

[1] Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity [J].

Baillargeon, JP ;

Jakubowicz, DJ ;

Iuorno, MJ ;

Jakubowicz, S ;

Nestler, JE .

FERTILITY AND STERILITY, 2004, 82 (04) :893-902

[2] Insulin sensitizers for polycystic ovary syndrome [J].

Baillargeon, JP ;

Iuorno, MJ ;

Nestler, JE .

CLINICAL OBSTETRICS AND GYNECOLOGY, 2003, 46 (02) :325-340

[3]

BAILLARGEON JP, 2005, 87 ANN M END SOC SAN, P27

[4] Selective insulin resistance in the polycystic ovary syndrome [J].

Book, CB ;

Dunaif, A .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (09) :3110-3116

[5] Clinical, endocrine and metabolic effects of acarbose, an α-glucosidase inhibitor, in PCOS patients with increased insulin response and normal glucose tolerance [J].

Ciotta, L ;

Calogero, AE ;

Farina, M ;

De Leo, V ;

La Marca, A ;

Cianci, A .

HUMAN REPRODUCTION, 2001, 16 (10) :2066-2072

[6] Impaired activation of phosphoinositide 3-kinase by insulin in fibroblasts from patients with severe insulin resistance and pseudoacromegaly - A disorder characterized by selective postreceptor insulin resistance [J].

Dib, K ;

Whitehead, JP ;

Humphreys, PJ ;

Soos, MA ;

Baynes, KCR ;

Kumar, S ;

Harvey, T ;

O'Rahilly, S .

JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (05) :1111-1120

[7] Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome [J].

Ehrmann, DA ;

Schneider, DJ ;

Sobel, BE ;

Cavaghan, MK ;

Imperial, J ;

Rosenfield, RL ;

Polonsky, KS .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (07) :2108-2116

[8] Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS) [J].

Fauser, BCJM ;

Chang, J ;

Azziz, R ;

Legro, R ;

Dewailly, D ;

Franks, S ;

Tarlatzis, BC ;

Fauser, B ;

Balen, A ;

Bouchard, P ;

Dahlgren, E ;

Devoto, L ;

Diamanti, E ;

Dunaif, A ;

Filicori, M ;

Homburg, R ;

Ibanez, L ;

Laven, J ;

Magoffin, D ;

Nestler, J ;

Norman, RJ ;

Pasquali, R ;

Pugeat, M ;

Strauss, J ;

Tan, S ;

Taylor, A ;

Wild, R ;

Wild, S ;

Ehrmann, D ;

Lobo, R .

HUMAN REPRODUCTION, 2004, 19 (01) :41-47

[9] Evidence for a primary abnormality of thecal cell steroidogenesis in the polycystic ovary syndrome [J].

GillingSmith, C ;

Story, H ;

Rogers, V ;

Franks, S .

CLINICAL ENDOCRINOLOGY, 1997, 47 (01) :93-99

[10]

King GL, 1999, DIABETES CARE, V22, pC31

← 1 2 →